All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for FERRING PHARMACEUTICALS INC. · biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · $80,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 3

Veterans

Issues related to veteran's care and veteran's reproductive care

Trade (domestic/foreign)

Issues related to pharmaceutical tariffs

Health Issues

Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA Pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.